Article 1 to 10 out of 11 concerning Microbix Biosystems Inc.
Microbix to spin off Urokinase into newly formed Klarogen Biotherapeutics(05/09/2008) Klarogen to acquire all remaining Urokinase inventory, sales and marketing infrastructure and NDA from ImaRx upon completion of financing Microbix Biosystems Inc. announced that it intends to spin off its Urokinase assets into a new private company, Klarogen Biotherapeutics Inc., which would become the sole commercial-scale manufacturer and supplier of the clot-busting drug after a ...
ALS Therapy Development Institute Signs Manufacturing Agreement with Microbix(10/18/2007) Microbix Biosystems Inc. announced that it has been selected by the ALS Therapy Development Institute (ALS TDI) in the U.S. to manufacture a series of adenoviruses that will be used in research aimed at fighting the disease Amyotrophic Lateral ...
Microbix mobilizes SWATT team to help companies worldwide expand flu vaccine production(08/15/2007) Microbix Biosystems Inc. is establishing a Special Workgroup for Applied Technology Transfer (SWATT) that shall be instrumental in helping manufacturers significantly boost the amount of flu vaccine produced throughout the world.The SWATT team will ...
Microbix identifies specific proteins that allow X and Y sperm cells to be separated(06/15/2007) Microbix Biosystems Inc. announced that it is has made a significant discovery that takes it a major step forward in commercializing its animal reproduction technology. The Company has been able to identify specific proteins that allow ...
Microbix granted patent on its Vaccine Technology(03/23/2007) Microbix Biosystems Inc. announced that it has been granted a patent by the Canadian Patent Office for its Vaccine Technology. This technology holds the promise of significantly boosting global production of influenza vaccines."This is a major ...
Microbix partners with Angiogen for urokinase cancer treatment(11/06/2006) Microbix Biosystems Inc. is partnering with Angiogen LLC to commercialize a novel technology for the treatment of solid cancers by exclusively providing the urokinase needed for Angiogen's patented drug therapy. According to the company, Microbix ...
Microbix takes over urokinase production from Genpharm(02/02/2006) Negotiations for the exclusive right to manufacture the drug for a new proprietary use Microbix Biosystems Inc. announced that it has taken over the production of its urokinase product from Genpharm Inc. and will directly operate the manufacturing facilities. The two companies, which have been working together over the past three ...
Top